Navigation Links
Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference
Date:11/26/2014

SAN DIEGO, Nov. 25, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will be presenting at the Piper Jaffray Healthcare Conference in New York on Wednesday, December 3, 2014 at 1:00 p.m. EDT/10:00 a.m. PDT. Dr. Helen Torley, President and Chief Executive Officer, will provide a corporate overview.

The presentation will be webcast through the "Investors" section of Halozyme's corporate website at www.halozyme.com, and a recording will be made available for 90 days following the event. To access the live webcast, please log on to Halozyme's website approximately 15 minutes prior to the presentation to register and download any necessary audio software.

About Halozyme
Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, which increase the dispersion and absorption of biologics, drugs and fluids. Halozyme's pipeline addresses therapeutic areas, including oncology, diabetes and dermatology that have significant unmet medical need today. The Company markets Hylenex® recombinant (hyaluronidase human injection) and has partnerships with Roche, Pfizer and Baxter. Halozyme is headquartered in San Diego, CA. For more information on how we are innovating, please visit our corporate website at www.halozyme.com.

Investor Contact:
Schond Greenway
Halozyme Therapeutics
858-704-8352
ir@halozyme.com

Media Contact:
Susan Neath Francis
212-301-7182
sfrancis@wcgworld.com

 

Logo - http://photos.prnewswire.com/prnh/20100302/LA63139LOGO


'/>"/>
SOURCE Halozyme Therapeutics, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Halozyme to Host First Quarter 2012 Financial Results Conference Call
2. Halozyme Reports First Quarter 2012 Financial Results
3. Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
4. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
5. Halozyme Confirms Baxter Has Received A Complete Response Letter For HyQ BLA
6. Halozyme Reports Second Quarter 2012 Financial Results
7. Halozyme to Host Third Quarter Financial Results Conference Call
8. Halozyme Therapeutics To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
9. Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
10. Halozyme Reports Fourth Quarter and Year End 2012 Financial Results
11. Halozyme Therapeutics to Present at the Barclays 2013 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2020)... ... August 27, 2020 , ... Bridge To A Cure Foundation announces the ... adult and pediatric neuro-oncologist who serves on the Board of Directors at The Preston ... University Medical School. , Internationally recognized, Dr. Friedman is a widely published author of ...
(Date:8/26/2020)... ... 26, 2020 , ... Unscrupulous sellers across the country are ... purification technologies, including GreenTech Environmental’s proprietary methods, have been used successfully to curb ... has published results of singular and scientific testing against the coronavirus. , As ...
(Date:8/26/2020)... ... August 26, 2020 , ... The Lymphoma Research ... lymphoma research and serving the lymphoma community through education programs, outreach initiatives and ... LRF Gala and Charity Auction on Wednesday, Sept. 30 . The “Finding ...
Breaking Medicine Technology:
(Date:8/28/2020)... ... August 28, 2020 , ... Ernst ... Mandeville was named an Entrepreneur Of The Year® 2020 Florida Award finalist. Now ... leaders whose ambitions deliver innovation, growth and prosperity as they build and sustain ...
(Date:8/28/2020)... ... 28, 2020 , ... The 15 scholarships being offered by ... Wellness mobile app and web-portal. NCPCV received a 2020 grant from Motorola Solutions ... year to organizations, such as Destination Imagination, which support and advance public safety ...
(Date:8/28/2020)... ... ... Integrated Viral Protection (IVP Air) today announced that the True North ... Biodefense Indoor Air Protection System that is the first system designed and proven to ... with the filtration system on September 8th. , The IVP Air S1 model ...
(Date:8/28/2020)... ANGELES (PRWEB) , ... August 28, 2020 , ... ... on international observations that strongly suggest that obese individuals are at an increased ... people are any more likely to catch COVID-19; however, because the same organ ...
(Date:8/27/2020)... ... August 27, 2020 , ... ... is a leading aesthetic and wellness retreat. The practice is centered on results ... of Las Vegas. , Designed to be a sanctuary for total body ...
Breaking Medicine News(10 mins):